Stephen Schultz | VP, IR |
Justin Gover | CEO & Executive Director |
Darren Cline | U.S. Chief Commercial Officer |
Christopher Tovey | COO |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | CFO |
Cory Kasimov | JPMorgan Chase & Co. |
Salveen Richter | Goldman Sachs Group |
Tazeen Ahmad | Bank of America Merrill Lynch |
Philip Nadeau | Cowen and Company |
Marc Goodman | SVB Leerink |
Paul Matteis | Stifel, Nicolaus & Company |
Serge Belanger | Needham & Company |
Esther Rajavelu | Oppenheimer |
Neena Bitritto-Garg | Citigroup |
Yatin Suneja | Guggenheim Securities |
David Kideckel | AltaCorp Capital |
Greetings and welcome to the GW Pharmaceuticals First Quarter 2020 Financial Results Call. [Operator Instructions].
It is now my pleasure to introduce your host, Mr. Stephen Schultz, Vice President, Investor Relations. Thank you, sir.